Civil Litigation
Business Torts Articles
-
This article discusses the ability for groups to insure agaist punitive damage awards. -
When is an owner liable to someone injured by the accumulation of ice and snow on a road or sidewalk? -
This can be either a civil or criminal wrong. Fraud includes anything intended to deceive, including all statement. -
This article discusses the legal concerns and considerations associated with electronic discovery. -
Intellectual Property, or "products of the mind," is generally classified as Patents, Copyrights, Trademarks, or Trade Secrets. Each form of Intellectual Property is subject to its own set of laws and rules on how it is created, protected, maintained, and utilized. While future articles will address each of these in more detail, this article will focus on the need to keep a close watch on the details of your Intellectual Property so that you can protect them and get value from them. -
Class actions can put defendants under enormous and undue pressure to settle or face a crippling verdict. That pressure is intensified when there is the specter of class-wide punitive damages. These awards can serve the state's legitimate interest in punishing and deterring unlawful conduct, and so punitive damages cannot be avoided completely in high-stakes litigation. -
In a recent decision, Utah Federal District Court Judge Dale Kimball sustained two employees' claims for intentional infliction of emotional distress against their former employer. The lawsuit was filed by a husband and wife who both worked for the same employer. They alleged that the employer's treatment of them after learning that the husband had AIDS was so callous and manipulative as to be actionable under the very high standard governing Utah's common-law tort of "outrage." -
Ways to protect your ideas and your business. -
What rights do you have under trade secret law? -
The FTC recently approved the merger of Pfizer Inc. and Pharmacia Corporation. Pfizer is purchasing Pharmacia for an estimated $60 billion solidifying its position as the world's largest pharmaceutical company. Pfizer will control 11 percent of the world's pharmaceutical market, up from 8 percent, with annual revenue estimated to increase to $46 billion from $32 billion.